Loading company…
Riskpilot
← Back to search
Sign in
Get full access
FYSIONORWAY AS
AS
Active
Org 922105022
Jegeråsen 28, 1362 Hosle
Physiotherapy activities · NACE 8695
Est. 2019
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 675K
-60% vs 2023
EBITDA margin
0.5%
-60% vs 2023
Equity ratio
47.3%
Financial strength
Net profit 2024
NOK 3K
-47% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 675K
-60%
EBITDA
NOK 3K
-60%
Net profit
NOK 3K
-47%
Total assets
NOK 396K
-44%
Equity
NOK 187K
+1%
Employees
1
—
Company information
Legal name
FYSIONORWAY AS
Org number
922105022
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
23. januar 2019
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Manuellterapi, fysioterapi og varesalg, investeringer.
Contact
Address
Jegeråsen 28, 1362 Hosle
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Physiotherapy activities
Companies in Bærum
All Norway companies
Revenue
NOK millions
0M
1M
1M
2M
2M
1M
2020
1M
2021
1M
2022
2M
2023
1M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
664
1 052
584
1 686
675
Staff expenses
−258
−516
−240
−1 396
−389
EBITDA
124
120
6
9
3
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
124
120
6
9
3
Net financials
−2
−3
−1
−3
−0
Profit before tax
123
118
5
6
3
Tax
15
26
1
1
1
Net profit
107
92
4
5
3
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
226
396
329
706
396
Equity
84
176
180
185
187
Long-term debt
0
0
0
0
0
Short-term debt
141
220
149
521
209
Total debt
141
220
149
521
209
Financial ratios
5-year trend
EBITDA margin
0.5%
This company
15.8%
Market median
-97% vs market
2020
2024
Equity ratio
47.3%
This company
38.2%
Market median
+24% vs market
2020
2024
Return on equity
1.3%
This company
18.4%
Market median
-93% vs market
2020
2024
Net profit margin
0.4%
This company
8.1%
Market median
-95% vs market
2020
2024
Asset turnover
1.71×
This company
1.12×
Market median
+53% vs market
2020
2024
Debt / equity
1.11×
This company
0.62×
Market median
-79% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
CT
Camilla Tveiten Fegth
Chief Executive Officer
Chief Executive Officer
2019
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
FYSIONORWAY AS
(this company)
BØLER FYSIKALSKE INSTITUTT AS
BLOCKS AS
Board network connections
Board members of FYSIONORWAY AS also hold positions in
0
other companies.
Person
Role here
Other companies
Camilla Tveiten Fegth
Chief Executive Officer
0 companies